Furthermore, TLR9 deficiency significantly reduced liver weights and ameliorated hepatic steatosis in HFD-induced NASH mice, indicating the protective role of TLR9 in hepatic dysmetabolism (64). Here, TLR9 is linked to metabolic dysfunction-associated steatohepatitis.